Effect of lycopene against cisplatin-induced acute renal injury in rats: Organic anion and cation transporters evaluation

Biological Trace Element Research

Volumn 158, Issue 1, 2014, Pages 90-95

  Erman, Fazilet ^a   Tuzcu, Mehmet ^a   Orhan, Cemal ^a   Sahin, Nurhan ^a   Sahin, Kazim ^a  

^a FIRAT UNIVERSITY   (Turkey)

Author keywords

Cisplatin; Kidney; Lycopene; MRPs; OATs OCTs

Indexed keywords

CISPLATIN; LYCOPENE; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 4; ORGANIC ANION TRANSPORTER; ORGANIC ANION TRANSPORTER 1; ORGANIC ANION TRANSPORTER 3; ORGANIC CATION TRANSPORTER; ORGANIC CATION TRANSPORTER 1; ORGANIC CATION TRANSPORTER 2; ABC TRANSPORTER; ABCC2 PROTEIN, RAT; ABCC4 PROTEIN, RAT; ANTIOXIDANT; CAROTENOID; CATECHOLAMINE TRANSPORTER; MULTIDRUG RESISTANCE PROTEIN; NEUROPROTECTIVE AGENT; SLC22A1 PROTEIN, RAT; SLC22A2 PROTEIN, RAT; SLC22A6 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; KIDNEY INJURY; MULTICENTER STUDY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; RAT; RENAL PROTECTION; UREA BLOOD LEVEL; ACUTE KIDNEY INJURY; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; METABOLISM; UPREGULATION; WESTERN BLOTTING; WISTAR RAT;

AVENA; RATTUS; RATTUS NORVEGICUS;

ACUTE KIDNEY INJURY; ANIMALS; ANTIOXIDANTS; ATP-BINDING CASSETTE TRANSPORTERS; BLOTTING, WESTERN; CAROTENOIDS; CATECHOLAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; CISPLATIN; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEUROPROTECTIVE AGENTS; ORGANIC ANION TRANSPORT PROTEIN 1; ORGANIC ANION TRANSPORTERS; ORGANIC ANION TRANSPORTERS, SODIUM-INDEPENDENT; ORGANIC CATION TRANSPORT PROTEINS; RATS, WISTAR; UP-REGULATION;

EID: 84897080904     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-014-9914-x     Document Type: Article

References (34)

1. Meyer KB, Medias E (1994) Cisplatin nephrotoxicity. Miner Electrolyte Metab 20:201-213 (Pubitemid 24320004)
2. Luke DR, Vadiei K, Lopez-Berestein G (1992) Role of vascular congestion in cisplatin-induced acute renal failure in the rat. Nephrol Dial Transplant 7:1-7
3. Kang DG, Lee AS, Mun YJ et al (2004) Butein ameliorates renal concentrating ability in cisplatin-induced acute renal failure in rats. Biol Pharm Bull 27:366-370 (Pubitemid 41685481)
4. Ashrafi F, Haghshenas S, Nematbakhsh M et al (2012) The role of magnesium supplementation in cisplatin-induced nephrotoxicity in a rat model: no nephroprotectant effect. Int J Prev Med 3:637-643
5. Sahin K, Sahin N, Kucuk O (2010) Lycopene and chemotherapy toxicity. Nutr Cancer 62:988-995
6. Kim YK, Jung JS, Lee SH et al (1997) Effects of antioxidants and ca2/in cisplatin-induced cell injury in rabbit renal cortical slices. Toxicol Appl Pharmacol 146:261-269 (Pubitemid 27481203)
7. Mora L dO, Antunes LMG, Francescato HDC et al (2003) The effects of oral glutamine on cisplatin-induced nephrotoxicity in rats. Pharmacol Res 47:517-522
8. Velmurugan ST, Santhiya ST, Nagini S (2004) Protective effect of S-allylcysteine and lycopene in combination against N-methyl-N′-nitro-N- nitrosoguanidine-induced genotoxicity. Pol J Pharmacol 56:241-245 (Pubitemid 38931390)
9. Tapiero H, Townsend DM, Tew KD (2004) The role of carotenoids in the prevention of human pathologies. Biomed Pharmacother 58:100-110 (Pubitemid 38264535)
10. Cohen LA (2002) A review of animal model studies of tomato carotenoids, lycopene, and cancer chemoprevention. Exp Biol Med 227:864-868
11. Kucuk O, Sarkar FH, Sakr W et al (2001) Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol Biomarkers Prev 10:861-868 (Pubitemid 32738598)
12. Kucuk O (2002) Chemoprevention of prostate cancer. Cancer Metastasis Rev 21:111-124
13. Kucuk O, Sarkar FH, Djuric Z et al (2002) Effects of lycopene supplementation in patients with localized prostate cancer. Exp Biol Med 227:881-885 (Pubitemid 35340342)
14. Amin AR, Kucuk O, Khuri FR et al (2009) Perspectives for cancer prevention with natural compounds. J Clin Oncol 27:2712-2725
15. Seren S, Lieberman R, Bayraktar UD et al (2008) Lycopene in cancer prevention and treatment. Am J Ther 15:66-81 (Pubitemid 351161184)
16. Yilmaz S, Atessahin A, Sahna E et al (2006) Protective effect of lycopene on adriamycin-induced cardiotoxicity and nephrotoxicity. Toxicology 218:164-171 (Pubitemid 41821347)
17. Dogukan A, Tuzcu M, Agca CA et al (2011) A tomato lycopene complex protects the kidney from cisplatin-induced injury via affecting oxidative stress as well as Bax, Bcl-2, and HSPs expression. Nutr Cancer 63:427-434
18. Atessahin A, Yilmaz S, Karahan I et al (2005) Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in rats. Toxicology 212:116-123 (Pubitemid 40981968)
19. Endou H (1998) Recent advances in molecular mechanisms of nephrotoxicity. Toxicol Lett 28:29-33
20. Inui KI, Masuda S, Saito H (2000) Cellular and molecular aspects of drug transport in the kidney. Kidney Int 58:944-958
21. Roch-Ramel F, Besseghir K, Murer H (1992) Renal excretion and tubular transport of organic anions and cations. In: Windhager EE (ed) Renal physiology, handbook of physiology, 2nd edn. Oxford University Press, New York, pp 2189-2262
22. Ullrich KJ (1994) Specificity of transporters for ' organic anions' and 'organic cations' in the kidney. Biochim Biophys Acta 1197:45-62
23. Launay-Vacher V, Izzedine H, Karie S et al (2006) Renal tubular drug transporters. Nephron Physiol 103:97-106
24. Morisaki T, Matsuzaki T, Yokoo K et al (2008) Regulation of renal organic ion transporters in cisplatin-induced acute kidney injury and uremia in rats. Pharm Res 25:2526-2533
25. Huang Q, Dunn RT 2nd, Jayadev S et al (2001) Assessment of cisplatin-induced nephrotoxicity by microarray technology. Toxicol Sci 63:196-207 (Pubitemid 32982793)
26. Demeule M, Brossard M, Beliveau R (1999) Cisplatin induces renal expression of P-glycoprotein and canalicular multispecific organic anion transporter. Am J Physiol 277:832-840
27. Ulu R, Dogukan A, Tuzcu M et al (2012) Regulation of renal organic anion and cation transporters by thymoquinone in cisplatin induced kidney injury. Food Chem Toxicol 50:1675-1679
28. Shimeda Y, Hirotani Y, Akimoto Y et al (2005) Protective effects of capsaicin against cisplatin-induced nephrotoxicity in rats. Biol Pharm Bull 28:1635-1638
29. Sung MJ, Kim DH, Jung YJ et al (2008) Genistein protects the kidney from cisplatin-induced injury. Kidney Int 4:1538-1547
30. Farombi EO, Shrotriya S, Na HK et al (2008) Curcumin attenuates dimethylnitrosamine-induced liver injury in rats through Nrf2-mediated induction of heme oxygenase-1. Food Chem Toxicol 46:1279-1287 (Pubitemid 351258204)
31. Sahin K, Tuzcu M, Gencoglu H et al (2010) Epigallocatechin-3-gallate activates Nrf2/HO-1 signaling pathway in cisplatin-induced nephrotoxicity in rats. Life Sci 87:240-245
32. Sun H, Frassetto L, Benet LZ (2006) Effects of renal failure on drug transport and metabolism. Pharmacol Ther 109:1-11 (Pubitemid 41740811)
33. Nowicki MT, Aleksunes LM, Sawant SP et al (2008) Renal and hepatic transporter expression in type 2 diabetic rats. Drug Metab Lett 2:11-17 (Pubitemid 351411256)
34. Aleksunes LM, Augustine LM, Scheffer GL et al (2008) Renal xenobiotic transporters are differentially expressed in mice following cisplatin treatment. Toxicology 250:82-88